Pharmaceutical

As the Trump administration seeks to align U.S. drug prices with lower reference costs in places like Europe, Eli Lilly’s CEO has cautioned that flaws...

CorMedix is expanding its portfolio of infectious disease products for hospitalized patients with the acquisition of another New Jersey-based commerci...

Pfizer CentreOne—the pharma giant's integrated CMO outfit—is leveraging lessons learned from the COVID pandemic as it works to redefine the nature of...

Only a few months after stepping into the role of senior VP of marketing and patient solutions for U.S. operations at Novo Nordisk, Ulrich Otte is no...

A federal court of appeals judge upheld a lower court's decision to dismiss a lawsuit challenging the constitutionality of the drug price negotiation...

In line with the Trump administration’s goal to curb the U.S.’ reliance on overseas drug manufacturing, the FDA has deployed a new program designed to...

The company hopes an important CVS deal and broader legal action against the makers of knockoff Wegovy can solidify its slipping position in the lucra...

One vaccine expert called the move, which cancels some $500 million in messenger RNA research contracts, a “giant step backward for science.”

In its latest earnings report, Iovance confirmed plans to reduce its workforce by 19% in a bid to save $100 million in yearly costs.

The smaller market now envisioned for vepdegestrant has changed both companies’ stance on their original deal, leading to negotiations that could eith...